Can convective therapies improve dialysis outcomes?

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 6, 2009, Pages 476-480

  Locatelli, Francesco ^a   Manzoni, Celestina ^a   Cavalli, Andrea ^a   Di Filippo, Salvatore ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Dialysis membranes; Hemodiafiltration; Hemofiltration; High flux hemodialysis

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; SERUM ALBUMIN; UREA;

ATHEROSCLEROSIS; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONVECTIVE THERAPY; DIALYSIS; EPIDEMIOLOGICAL DATA; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFUSION; KIDNEY FAILURE; KIDNEY FUNCTION; MALNUTRITION; MEMBRANE PERMEABILITY; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REVIEW; RISK FACTOR; RISK REDUCTION; SURVIVAL RATE; THERMODYNAMICS; TREATMENT OUTCOME; ARTIFICIAL MEMBRANE; BLOOD; DIFFUSION; EVIDENCE BASED MEDICINE; INSTRUMENTATION; METABOLISM; MOLECULAR WEIGHT; PATIENT SELECTION; PERMEABILITY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TIME; UREMIA;

BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DIFFUSION; EVIDENCE-BASED MEDICINE; HEMODIAFILTRATION; HUMANS; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; PATIENT SELECTION; PERMEABILITY; RENAL DIALYSIS; RISK ASSESSMENT; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME; UREA; UREMIA;

EID: 73349139235     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283318e8b     Document Type: Review

References (23)

1. Yoshino M, Kuhlmann MK, Kotanko P, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 2006; 17:3510-3519. (Pubitemid 44865294)
2. Stenvinkel P, Heimburger O, Paultre F, et al. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney lnt 1999;55:1899-1911. (Pubitemid 29197978)
3. Schindler R, Boenisch O, Fischer C, Frei U. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol 2000; 53:452-459. (Pubitemid 30390075)
4. Eknoyan G, Beck GJ, Cheung AK, et al., for the Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010-2019.
5. Cheung AK, Levin NW, Greene T, et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003; 14:3251-3263. (Pubitemid 37509301)
6. Delmez JA, Yan G, Bailey J, et al. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 2006; 47:131-138. (Pubitemid 41828275)
7. Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20:645-654. This multicenter, prospective, randomized clinical study was specifically designed to include incident high-risk patients and demonstrated the effect of high-flux dialysis in improving survival in this patient population.
8. Locatelli F, Mastrangelo F, Redaell B, et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996; 50:1293-1302. (Pubitemid 26342822)
9. Port FK, Wolfe RA, Hulbert-Shearon TE, et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001; 37:276-286.
10. Chauveau P, Nguyen H, Combe C, et al. Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005; 45:565-571. (Pubitemid 40341336)
11. Krane V, Krieter DH, Olschewski M, et al. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 2007; 49:267-275. (Pubitemid 46178399)
12. Cheung AK, Rocco MV, Yan G, et al., for the HEMO Study Group. Serum ß2-microglobulin levels predict mortality in dialysis patients: results of the HEMO Study. J Am Soc Nephrol 2006; 17:546-555.
13. van Dijk PC, Jager KJ, Stengel B, et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney lnt 2005; 67:1489-1499.
14. Pifer TB, McCullough KP, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney int 2002; 62:2238-2245. (Pubitemid 35366181)
15. Owen WF, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329:1001-1006. (Pubitemid 23307908)
16. The DOPPS Report, 2004. http://www.dopps.org/pdf/dopps-report-2004.pdf. Accessed 30 June, 2007.
17. Cheung AK, Greene T, Leypoldt JK, et al. Association between serum ß2-microglobulln level and infectious mortality In hemodialysis patients. Clin J Am Soc Nephrol 2008; 3:69-77.
18. Okuno S, lshimura E, Kohno K, et al. Serum ß2-mlcroglobulin level is a significant predictor of mortality In maintenance haemodialysis patients. Nephrol Dial Transplant 2009; 24:571-577.
19. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006; 69:2087-2093. (Pubitemid 43924275)
20. Vaslakl L, Major L, Berta K, et al. On-line haemodlafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006; 24:163-173. (Pubitemid 43259169)
21. Lornoy W, De Meester J, Because I, et al. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 2006; 16:47-53. (Pubitemid 43088755)
22. Lornoy W, Becaus I, BilliouwJM, et al. On-line haemodiafiltration. Remarkable removal of ß2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000; 15 (S1):49-54.
23. Santoro A, Mancini E, Bolzani R, et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis 2008; 52:507-518. This is an interesting randomized trial comparing on-line high-flux hemofiltration and low-flux hemodialysis. Unfortunately, the sample size is rather small.